Mark'ennovy
Mark'ennovy manufactures individually crafted soft contact lenses — including MYLO myopia management and EDOF presbyopia lenses — for sale exclusively through eye care professionals across 10 European markets and 35+ distribution countries.
- Company typePrivate
- Founded1997
- HeadquartersMajadahonda, Spain
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Mark'ennovy does
Mark'ennovy Personalized Care, S.L. is a privately held manufacturer of individually crafted soft contact lenses, headquartered in Majadahonda (Madrid), Spain, and operating as a subsidiary of the global eye health company Euclid Vision Group. Founded in 1997 by CEO Georges Sarrouf, the company designs, manufactures, and markets a portfolio of monthly and 3-monthly replacement soft contact lenses — spanning silicone hydrogel (Saphir Rx, Xtensa SiHy, Blu:gen/Blu:kidz/Blu:ssentials), bio-inspired hydrogel (Gentle 80, Gentle 59 using Ori:gen technology), and conventional hydrogel (Saphir, Equilibria) materials — with more than 1 billion parameter combinations covering sphere, cylinder, axis, addition, diameter, and base curve. Core differentiating platforms include MYLO (pediatric myopia management) and EDOF (presbyopia), both powered by Extended Depth of Focus optical technology exclusively licensed worldwide from the Brien Holden Vision Institute in 2018.
The company sells exclusively through eye care professionals (optometrists, contact lens practitioners, and optical chains) and does not transact directly with consumers. Pricing is quote-based and quote-derived through Business Account Managers, with a recurring revenue structure tied to monthly and quarterly replacement cycles. Mark'ennovy holds ISO 13485 certification and CE marking across its portfolio, with manufacturing supported by Vista Optics (acquired 2010) in Widnes, UK as the centre of materials innovation. Direct subsidiaries operate in Spain, the UK, Italy, Germany, and Switzerland; a distribution network extends the brand to more than 35 countries including Latin America.
The go-to-market relies on field sales via Business Account Managers, an optician-led Professional Affairs Team providing in-practice training and fitting support, and the mark'ennovy Academy training platform. An 'Individually Yours' personalization suite — engraving patient names on boxes, eye-specific labelling, and personalized packaging — reinforces stickiness with both clinicians and end patients. In September 2018 the company completed a significant debt and equity funding package with Bond Capital Partners (with Alantra also referenced) to accelerate global development of its custom fit extended range contact lens business.
Mark'ennovy firmographics
Firmographics- Name
- Mark'ennovy
- Legal name
- MARK'ENNOVY PERSONALIZED CARE, S.L.
- Website
- https://markennovy.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Mark'ennovy manufactures individually crafted soft contact lenses — including MYLO myopia management and EDOF presbyopia lenses — for sale exclusively through eye care professionals across 10 European markets and 35+ distribution countries.
- Ownership category
- akta.pro rank
Mark'ennovy industry classification
Industry- Product category
- Contact Lenses
- NAICS
- Ophthalmic Goods Manufacturing (339115)
- SIC
- Ophthalmic Goods (3851)
- akta.pro primary industry
- Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE)
- akta.pro secondary industry
- Contact Lens Specialty & Myopia Control (HLAKAKAK)
Keywords
Where Mark'ennovy is headquartered
LocationHeadquarters
- HQ city
- Majadahonda
- HQ country
- Spain
- HQ region
- Europe
Offices7 records
Markets served
Mark'ennovy business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Contact Lens Sales: Mark'ennovy manufactures and sells individually crafted soft contact lenses to eye care professionals. Products include monthly and quarterly replacement lenses for myopia, hyperopia, astigmatism, and presbyopia correction. Revenue is generated through direct sales to optometry practices and optical chains.
- Training and Education Services: The company provides free professional training through mark'ennovy Academy, including webinars, master classes, and in-practice training sessions. This supports product adoption and customer loyalty rather than generating direct revenue.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Bespoke contact lenses - quote-based pricing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Mark'ennovy product offering
Product offeringCore offering
Mark'ennovy manufactures and sells individually crafted soft contact lenses — including monthly silicone hydrogels, bio-inspired hydrogels, and 3-monthly lenses — for the correction of myopia, hyperopia, astigmatism, and presbyopia. Products are made-to-order with more than 1 billion parameter combinations and sold exclusively to eye care professionals (optometrists and contact lens opticians).
Product overview
Mark'ennovy is a manufacturer of individually crafted soft contact lenses, offering a comprehensive portfolio of monthly and 3-monthly replacement lenses across multiple materials and designs. The product portfolio centers on precision soft contact lenses with over 1 billion customization parameters, including silicone hydrogel options (MYLO, EDOF, Xtensa SiHy, Blu:gen, Saphir Rx), bio-inspired hydrogels (Gentle 80, Gentle 59), and conventional hydrogels (Saphir, Equilibria). MYLO and EDOF are powered by Brien Holden Vision Institute's patented Extended Depth of Focus (EDOF) technology for myopia management and presbyopia correction respectively. The company also provides the Individually Yours personalization service and Mark'ennovy Academy training platform for eye care professionals.
Differentiator
Problem solved
Functional benefit
Brands
- MYLO: Monthly disposable silicone hydrogel contact lens designed with BHVI's patented EDOF technology to slow the progression of myopia. Available in spherical and toric versions.
- Individually Yours
- Markennovy Academy
Products and services
- MYLO Monthly disposable silicone hydrogel contact lens powered by BHVI patented Extended Depth of Focus (EDOF) optical design, designed to slow the progression of myopia in children and adolescents. Available in spherical and toric versions with an extended parameter range, and prescribed through eye care professionals trained on myopia management.
- EDOF Individually crafted monthly contact lens for presbyopia correction, powered by Brien Holden Vision Institute's patented Extended Depth of Focus technology to provide clear vision at all distances. Available in spherical, toric, and multifocal geometries and individually customized to patient parameters.
- EDOF 59 Latest EDOF-powered addition to Mark'ennovy's presbyopia portfolio, targeted at emerging presbyopes and individually crafted for emerging presbyopic patients.
- Xtensa SiHy Monthly moulded silicone hydrogel contact lens providing excellent vision, eye health and comfort with oxygen transmissibility of 119 Dk/t and a Class 1 UV filter. Available in spherical, toric and multifocal geometries.
- Blu:gen Monthly silicone hydrogel contact lens combining Class 1 UV filter with selective Blue Light Blocking to protect eyes from UV and high-energy blue light, with the lowest modulus (0.25 MPa) among silicone hydrogels on the market.
- Blu:kidz Child-friendly monthly silicone hydrogel contact lens with Class 1 UV filter and selective Blue Light Blocking, designed for small eyes with an extended parameter range and green handling tint for easier use by children and adolescents.
- Saphir Rx World's first individually crafted monthly silicone hydrogel contact lens, with high water content, low dehydration, a highly lubricious surface (CoF = 0.02) and a low modulus (0.33 MPa) for excellent comfort and oxygen transmission.
- Gentle 80 Bio-inspired monthly hydrogel contact lens using Ori:gen Technology to imitate natural corneal properties, with 80% water content, low dehydration, and the lowest modulus (0.16 MPa) on the market. Winner of the 2015 Optician Award for Contact Lens Product of the Year.
- Gentle 59 Bio-inspired monthly hydrogel contact lens using Ori:gen Technology with high surface lubricity (CoF = 0.05), low dehydration (<1%), and a calibrated modulus (0.36 MPa) for optimal handling and vision quality.
- Saphir 3-monthly replacement silicone hydrogel contact lens offering a longer replacement cycle for patients accustomed to quarterly wear, available in multifocal and toric configurations.
- Equilibria 3-monthly replacement conventional (non-silicone) hydrogel contact lens offering good water retention and tensile properties for patients already accustomed to quarterly replacement cycles.
Quantifiable outcome
- Studies show MYLO with EDOF technology effective in slowing myopia progression in children
- +2 more outcomes
Companies that use Mark'ennovy
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles1 record
Mark'ennovy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Mark'ennovy partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Brien Holden Vision InstitutecoreWorldwide exclusive licensing agreement signed in 2018 for innovative myopia management and presbyopia soft lens technologies. The partnership brings BHVI's patented Extended Depth of Focus (EDOF) design to market, powering MYLO for myopia management and EDOF for presbyopia correction.
- Vista OpticscoreAcquired in 2010, Vista Optics became the epicenter of materials innovation for mark'ennovy. Vista Optics' expertise in contact lens materials complements mark'ennovy's growing portfolio of individually crafted lenses.
- Euclid Vision GroupcoreMark'ennovy is a subsidiary of the global eye health company Euclid Vision Group. The group includes Vista Optics Limited, Markennovy Personalized Care Limited, Markennovy Srl, Markennovy GmbH, Markennovy Material Sciences Ltd, and Markennovy Switzerland Subsidiary Mepc SL.
- LinkedIn Spain SLminorLinkedIn is used for job candidate recruitment and management. Mark'ennovy uses the platform to source potential employees and communicate with Euclid Vision group companies regarding candidates.
- SGS (Notified Body)minorSGS performs external audits of mark'ennovy's Quality Management System and records according to their audit program to confirm validity of CE marking and ISO 13485 certificates.
Scale indicators3 records
Recent moves9 records
Expansion highlights6 records
Mark'ennovy competitors and assessment
Company assessmentBroad incumbents
- Alcon: Global eye care leader with DAILIES, Air Optix, and Precision1 contact lens portfolios plus growing presbyopia/myopia offerings. Comparable as a broad incumbent in soft CL and vision correction rather than as a custom-lens specialist.
- Johnson & Johnson Vision: Owner of the Acuvue brand, the world's largest soft contact lens franchise. Competes with Mark'ennovy across the soft CL category and is actively entering myopia management; comparable as a broad incumbent rather than a like-for-like custom manufacturer.
- Bausch + Lomb: Global mass-market contact lens and ophthalmic products incumbent (Biotrue, Ultra). Overlaps with Mark'ennovy across the broader contact lens and myopia/presbyopia categories but operates at much greater scale and with stock-parameter rather than custom lenses as its core.
Direct peers
- CooperVision: One of the world's largest soft contact lens manufacturers with a strong specialty/custom portfolio (Biofinity, MiSight 1 day for myopia management). Directly comparable to Mark'ennovy on custom soft CL manufacturing, myopia management strategy, and ECP distribution model, though at significantly greater scale.
- Menicon: Japanese specialty contact lens manufacturer focused on rigid gas permeable, orthokeratology, and myopia management lenses. Comparable to Mark'ennovy in serving hard-to-fit prescriptions and pediatric myopia with custom manufacturing and ECP-exclusive channels.
Emerging players
- Euclid Systems Corporation: Orthokeratology lens manufacturer focused on overnight corneal reshaping for myopia management. Comparable to Mark'ennovy in the pediatric myopia management category but differentiated by ortho-K modality vs Mark'ennovy's soft EDOF MYLO lens.
- SynergEyes: US-based specialty contact lens company focused on hybrid and scleral lenses for irregular corneas and complex fits. Comparable to Mark'ennovy in serving hard-to-fit prescriptions through custom manufacturing via ECP channels, but smaller and more niche.
- X-Cel Specialty Contacts: US specialty contact lens lab producing custom soft and gas permeable lenses including tint, prosthetic, and keratoconus designs. Comparable to Mark'ennovy in custom soft lens manufacturing through ECP channels, with a regional US focus.
Others
- Contamac: UK-based manufacturer of contact lens and intraocular lens materials and equipment, supplying the broader specialty CL industry. Related to Mark'ennovy as a materials/equipment counterpart rather than a direct competitor.
Regional players
- SEED Co., Ltd. Japanese contact lens manufacturer with a portfolio spanning daily, two-week, and monthly soft lenses plus specialty products. Comparable to Mark'ennovy as a soft CL manufacturer but concentrated in Japan/Asia rather than Europe.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Mark'ennovy social profiles
Digital presenceMark'ennovy compliance and trust
Trust signalCompliance2 records
Mark'ennovy financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mark'ennovy leadership team
Management profileNumber of profiles
Profiles4 records
Mark'ennovy subsidiaries and ownership
Company hierarchySubsidiaries6 records
Mark'ennovy funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mark'ennovy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mark'ennovy
What does Mark'ennovy do?
Mark'ennovy manufactures and sells individually crafted soft contact lenses — including monthly silicone hydrogels, bio-inspired hydrogels, and 3-monthly lenses — for the correction of myopia, hyperopia, astigmatism, and presbyopia. Products are made-to-order with more than 1 billion parameter combinations and sold exclusively to eye care professionals (optometrists and contact lens opticians).
Is Mark'ennovy a public or private company?
Mark'ennovy is a private company. It is classified as corporate owned and is currently operating.
When was Mark'ennovy founded?
Mark'ennovy was founded in 1997. It employs 101 to 250 people.
Where is Mark'ennovy based?
Mark'ennovy is headquartered in Majadahonda, Spain, in the Europe region.
How does Mark'ennovy make money?
Two revenue lines are on record. Contact Lens Sales are the primary driver. The others are training and Education Services.
Who are Mark'ennovy's main competitors?
Broad incumbents on record are Alcon, Johnson & Johnson Vision and Bausch + Lomb. Direct peers are CooperVision and Menicon. Emerging players are Euclid Systems Corporation, SynergEyes and X-Cel Specialty Contacts. Contamac is listed as an others. SEED Co., Ltd. is listed as a regional player.
Does Mark'ennovy have an API?
No public API is recorded for Mark'ennovy.
What industry is Mark'ennovy in?
Mark'ennovy's product category is Contact Lenses. Its primary akta.pro industry code is HLAHAJAE, Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions), with a secondary code of HLAKAKAK, Contact Lens Specialty & Myopia Control. Its NAICS code is 339115 and its SIC code is 3851.